Full text in pdf format
Chromosome sensitivity tobleomycin in G2 lymphocytes fromDown syndrome patients
Marlíse Ladvocat Bartholomei-Santos; Edmundo José de Lucca
Departamento de Genética, Instituto de Biociências, Universidade Estadual Paulista, 18618-000 Botucatu, SP, Brasil. Send correspondence to E.J.L.
ABSTRACT
Several studies have demonstrated that lymphocytes from patients with Down syndrome (DS) exhibit an increased frequency of chromosome aberrations when they are exposed to ionizing radiation or to chemicals at the G0 or G1 phases of the cell cycle, but not at G2, when compared to normal subjects. To determine the susceptibility of DS lymphocytes at G2 phase, bleomycin, a radiomimetic agent, was used to induce DNA breaks in blood cultures from 24 Down syndrome patients.
All the patients with DS showed free trisomy 21 (47,XX + 21 or 47,XY + 21). Individuals that showed an average number of chromatid breaks per cell higher than 0.8 were considered sensitive to the drug. No control child showed susceptibility to bleomycin, and among the 24 patients with DS, only one was sensitive to the drug.
No significant difference was observed between the two groups, regarding chromatid break frequencies in treated G2 lymphocytes. The distribution of bleomycin-induced breaks in each group of chromosomes was similar for DS and controls. No significant difference was found in the response to bleomycin between male and female subjects. Probably, the main factor involved in chromosome sensitivity of lymphocytes from patients with DS is the phase of the cell cycle in which the cell is treated.
Keywords: Down syndrome; tobleomycin; G2 lymphocytes.
REFERENCES
Bartholomei-Santos, M.L. and Lucca, E.J. (1995). Genetic susceptibility to bleomycin: a twin study. Rev. Ciênc. Bioméd. 16: 47-53.
Campos, H. (1983). Estatística Experimental Não-Paramétrica. ESALQ, Piracicaba, pp. 349.
Cherry, L.M. and Hsu, T.C. (1983). Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res. 3: 367-372.
Countryman, P.I., Heddle, J.A. and Crawford, E. (1977). The repair of X-ray-induced chromosomal damage in trisomy 21 and normal diploid lymphocytes. Cancer Res. 37:52-58.
Dekaban, A.S., Thron, R. and Steusing, J.K. (1966). Chromosomal aberrations in irradiated blood and blood cultures of normal subjects and of selected patients with chromosomal abnormality. Radiat. Res. 27: 50-63.
Fong, C. and Brodeur, G.M. (1987). Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet. Cytogenet. 28: 55-76.
Gattás, R.R. (1978). Elementos de Probabilidade e Inferência. Atlas São Paulo, São Paulo, pp. 267.
Hopwood, V., Hsu, T.C., Pathak, S., Ramkissoon, D., Newell, G.R. and Martin, J.D. (1989). Cytogenetic characteristics in a family: fragile 16q22, giant satellite, aneuploidy, and bleomycin sensitivity of three generations. Rev. Bras. Genet. 12: 379-390.
Hsu, T.C. (1987). Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro 23: 591-603.
Hsu, T.C., Cherry, L.M. and Samaan, N.A. (1985). Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet. Cytogenet. 17: 307-313.
Hsu, T.C., Johnston, D.A., Cherry, L.M., Ramkissoon, D., Schantz, S.P., Jessup, J.M., Winn, R.J., Shirley, L. and Furlong, C. (1989). Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer 43: 403-409.
Iijima, K., Morimoto, K., Koizumi, A., Higurashi, M. and Hirayama, M. (1984). Bleomycin-induced chromosomal aberrations and sister chromatid exchanges in Down lymphocyte cultures. Hum. Genet. 66: 57-61.
Lambert, B., Hansson, K., Bui, T.H., Funes-Cravioto, F., Lindstein, J., Holmberg, M. and Strausmanis, R. (1976). DNA repair and frequency of X-ray and U.V.-light induced chromosome aberrations in leukocytes from patients with Down's syndrome. Ann. Hum. Genet. 39: 293-303.
Leonard, J.C. and Merz, T. (1983). The influence of cell cycle kinetics on the radiosensitivity of Down syndrome lymphocytes. Mutat. Res. 109: 111-121.
Leonard, J.C. and Merz, T. (1987). Chromosomal aberrations in irradiated Down's syndrome fibroblasts. Mutat. Res. 180: 223-230.
Morimoto, K., Kaneko, T., Iijima, K. and Koizumi, A. (1984). Proliferative kinetics and chromosome damage in trisomy 21 lymphocyte cultures exposed to y--rays and bleomycin. Cancer Res. 44: 1499-1504.
Paris Conference (1972). Standardization in human cytogenetics. Chromosome measurements. Cytogenetics 11: 313-362.
Pelz, L., Götz, J., Kruger, G. and Witt, G. (1988). Increased methotrexate-induced chromosome breakage in patients with free trisomy 21 and their parents. Hum. Genet. 81: 38-40.
Preston, R.J. (1981). X-ray-induced chromosome aberrations in Down lymphocytes: an explanation of their increased sensitivity. Environ. Mutagen. 3: 85-89.
Sales, M.M. (1991). Suscetibilidade genética à bleomicina: estudo em famílias de pares de gêmeos suscetíveis. Monografia de Licenciatura em Ciências Biológicas, Instituto de Biociências, Universidade Estadual Paulista, Botucatu, SP.
Sandberg, A.A. (1986). The chromosomes in human leukemia. Semin. Hematol. 23: 201-217.
Shafik, H.M., Au, W.W. and Legator, M.S. (1988). Chromosomal radiosensitivity of Down syndrome lymphocytes at different stages of the cell cycle. Hum. Genet. 78: 71-75.
Shubber, E.K., Hamami, H.A., Allak, B.M.A. and Khaleel, A.H. (1991). Sister chromatid exchange in lymphocytes from infants with Down syndrome. Mutat. Res. 248: 61-72.
Vijayalaxmi, A. and Evans, H.J. (1982). Bleomycin-induced chromosomal aberrations in Down's syndrome lymphocytes. Mutat. Res. 105: 107-113.
Voreschovsky, I. and Juraskova, V. (1990). Bleomycininduced chromosomal damage in tuberous sclerosis. Jpn. J. Hum. Genet. 35: 207-213.
Yanagisawa, S. (1978). Sister chromatid exchanges and the cell cycle in peripheral blood lymphocytes of Down syndrome. Proc. Japan Acad. 54 (ser. B): 173-178.
Zar, J.H. (1984). Bioestatistical Analysis. Prentice Hall International Editions, Englewood Cliffs, pp. 718.